Pink and Pearl campaign to link mammography visits with lung cancer screening at Christian Hospital.

Evaluating the Implementation and Effectiveness of the Pink and Pearl Campaign on Lung Cancer Screening at Christian Hospital

Not applicable Interventional Washington University School of Medicine · NCT07146568

This program will try to increase lung cancer screening among women aged 50–80 who come for mammograms at Christian Hospital.

Quick facts

PhaseNot applicable
Study typeInterventional
Enrollment5515 (estimated)
Ages20 Years and up
SexAll
SponsorWashington University School of Medicine Academic / other
Locations1 site (St Louis, Missouri)
Trial IDNCT07146568 on ClinicalTrials.gov

What this trial studies

The breast radiology service at Christian Hospital will implement the Pink & Pearl campaign within mammography clinics to promote awareness, referral, and completion of low-dose CT lung cancer screening among eligible women. The campaign leverages existing nurse navigation and referral pathways to primary care or screening services to support shared decision-making. Evaluation is guided by the Integrated Screening Action Model and uses an explanatory sequential mixed-methods design that combines quantitative measures of screening uptake with qualitative interviews and surveys. Primary outcomes include changes in referral and completion rates for lung cancer screening and characterization of implementation barriers and facilitators.

Who should consider this trial

Good fit: Ideal candidates are women aged 50–80 receiving screening mammography at Christian Hospital, especially those with a smoking history meeting lung screening criteria (about 20 pack-years, current or quit within 15 years).

Not a fit: Women outside the 50–80 age range, those not using Christian Hospital mammography services, men, or patients with limited life expectancy or prior lung cancer are unlikely to benefit from this campaign.

Why it matters

Potential benefit: If successful, the campaign could increase use of low-dose CT screening and help detect lung cancer earlier in eligible women.

How similar studies have performed: Navigation and outreach programs have increased lung screening uptake in some settings, but explicitly linking mammography clinics to lung screening is a relatively novel approach with limited prior data.

Eligibility criteria

Show full inclusion / exclusion criteria
Eligibility Criteria - Interventional Study

* Undergoing screening mammography at Christian Hospital
* Between the ages of 50-80 years (inclusive)

Eligibility Criteria - Survey and Interview Sub-Studies

* Part of the interventional study
* Reporting a 20 pack-year equivalent of either current smoking history or have quit in the past 15 years
* Can speak and understand English
* Not diagnosed with a serious health problem that will limit life expectancy (such as previous history of lung cancer, symptoms of lung cancer such as hemoptysis or unexplained weight loss of more than 6.8 kg (15 lb) in the previous year)
* Willing and able to get treatment if lung cancer is found
* Able to understand and willing to sign an IRB-approved written informed consent document

Eligibility Criteria - Providers

* At least 20 years of age
* Involved in the breast radiology service or referred at least one patient to the Pink \& Pearl Campaign
* Able to provide verbal consent to participate in the interview

Where this trial is running

St Louis, Missouri

Study contacts

How to participate

  1. Review the eligibility criteria above with your treating physician.
  2. Visit the official trial page on ClinicalTrials.gov for the most current contact information and recruitment status.
  3. Contact the listed study coordinator or principal investigator to request pre-screening. Pre-screening is free and never obligates you to enroll.
Conditions Lung CancerCancer of the LungLung cancer screeningPink and Pearl CampaignBreast cancer screeningLow-dose computed tomographySmoking historyHealth disparities
Last reviewed 2026-06-13 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.